Press releases

ExpressCells congratulates our Co-Founder, Oscar Perez Leal and his colleagues for the first publication featuring ExpressCells’ FAST-HDR gene editing system. Learn more about how FAST-HDR can help your cell-based research at xpresscells.com.

January 4th, 2022 | Press releases

“We believe the FAST-HDR system is a versatile methodology for developing endogenous tagging with CRISPR according to the needs of the researcher, as it works on any cell line, facilitates multiplexing, and allows the use of any protein tag.” Download Full Press Release Dedicated to Making Your Research Better ExpressCells has 13 catalog cell lines […]

ExpressCells Completes Series A2 Financing

April 8th, 2021 | Press releases

Extension of Series A Supports Operations Expansion and Increased Promotion We are pleased to announce that ExpressCells has completed an extension of its Series A financing round. $590,500 was raised in this Series A2 round from both existing and new investors. This round was oversubscribed by 18%. Our new investors in ExpressCells include the MIT […]

ExpressCells Announces First Patent for Core FAST-HDR Technology

January 19th, 2021 | Press releases

Technology Allows Faster Creation of Knock-In Cell Lines with Multiple Genes Inserted PHILADELPHIA – Jan. 19, 2021 – PRLog — ExpressCells, Inc. (“ExpressCells”), a genetic engineering company that creates knock-in cell lines for biological research, announces the granting of the first patent for its core FAST-HDR gene editing technology. The United States Patent & Trademark […]

ExpressCells named as one of top three startups in inaugural National Venture Plan Competition (NVPC) by Pismo Ventures

December 15th, 2020 | Press releases

Inaugural Event Provided Startup Businesses Unprecedented Access to Venture and Investment Industry Experts ExpressCells was named the top life sciences company–and one of the top three winners–in an inaugural National Venture Plan Competition (NVPC) by Pismo Ventures, which provided unprecedented, once-in-a-lifetime access for 197 startups to more than 160 investors, from 42 VCs and Angel […]

Entrepreneur magazine features ExpressCells as one of Pepperdine’s Most Fundable Companies of 2020

November 24th, 2020 | Press releases

Graziadio Business School announces third annual list and highest participation to date. DOWNLOAD LIST Source: Pepperdine’s Most Fundable Companies of 2020

ExpressCells is honored to have been chosen as a 2020 Most Fundable Company by the Pepperdine Graziadio Business School.

October 16th, 2020 | Press releases

Pepperdine Graziadio identifies and connects promising early-stage companies with resources they need through the school’s Most Fundable Companies surveys. Companies are evaluated based on the viability of their business model, size of addressable market, management team expertise, board of advisors, and competitive advantage in their market. ExpressCells is proud to share a spot amongst the […]

Pin It on Pinterest